ArticleScientific reports2026
Early age at smoking initiation is associated with elevated cardiovascular disease and mortality risk in a nationwide population-based cohort.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Smoking is a major cause of cardiovascular diseases, including myocardial infarction (MI) and stroke. However, the role of age at smoking initiation in cardiovascular risk has not been fully established. We selected 9,295,979 Korean adults without preexisting cardiovascular diseases who underwent health screening in 2009. The association of age at initiation with incident MI, stroke, MI or stroke, and all-cause mortality was analyzed using Cox proportional hazard models stratified or adjusted for total pack-years (PY). Among the 3,724,368 smokers, 876,740 smokers (23.5%) started before age 20, and 75,299 smokers (2.0%) had age at initiation < 15. Over a nine-year follow-up, ≥ 20 PY smokers with age at initiation < 20 had the highest risks of MI (adjusted hazard ratio (HR), 2.43; 95% confidence interval (95% CI), 2.35-2.51), stroke (HR 1.78, 95% CI 1.73-1.83), MI or stroke (HR 2.00, 95% CI 1.96-2.04), and death (HR 1.82, 95% CI 1.79-1.85) relative to nonsmokers, significantly higher than in ≥ 20 PY smokers with initiation age ≥ 20. Earlier age at initiation was associated with increasing PY-adjusted risks of each outcome (p for trend < 0.001 each). Age at initiation also had significant interactions with total PY for each outcome (p < 0.001 each), with PY-dependent risk increases accentuated by earlier initiation. Early age at smoking initiation is associated with increased risks of MI and stroke. Focused smoking prevention measures may be warranted for both adolescents and young adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.